0001950047-24-004908.txt : 20240620 0001950047-24-004908.hdr.sgml : 20240620 20240620152345 ACCESSION NUMBER: 0001950047-24-004908 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240620 DATE AS OF CHANGE: 20240620 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nurix Therapeutics, Inc. CENTRAL INDEX KEY: 0001549595 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 270838048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39398 FILM NUMBER: 241055916 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (415) 660-5320 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: Nurix, Inc. DATE OF NAME CHANGE: 20120509 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: van Houte Hans CENTRAL INDEX KEY: 0001817217 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O NURIX THERAPEUTICS, INC. STREET 2: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 144 1 primary_doc.xml 144 0001817217 XXXXXXXX LIVE 0001549595 NURIX THERAPEUTICS INC 001-39398 1700 Owens Street, Suite 205 San Francisco CA 94158 4156605320 JOHANNES VAN HOUTE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

20000 368800.00 59304000 06/20/2024 NASDAQ Common 05/31/2022 Previously Exercised Stock Options ISSUER N 20000 05/31/2022 Cash N 10b5-1 Sales for JOHANNES VAN HOUTE

1700 Owens Street, Suite 205 San Francisco CA 94158

Common 05/02/2024 3499 44878.17 06/20/2024 05/30/2023 /s/ Johannes van Houte